Researchers from The University of Texas MD Anderson Cancer Center and Sarah Cannon Research Institute have used ripretinib and surgical removal of a tumour to successfully treat a patient with recurring gastrointestinal cancer, carrying a KIT exon 11 mutation. The patient received 43 months of treatment, longer than current ripretinib clinical trials, which are reported to have improved clinical outcomes.
Man who stole 2 gold bars from Colorado woman in malware scam sentenced to 6 years in prison
Sagar Patel, 27, has been sentenced to six years in prison by a Colorado judge for stealing two gold bars from a 79-year-old woman. She
